These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

943 related articles for article (PubMed ID: 7527815)

  • 21. c-kit expression by B cell precursors in mouse bone marrow. Stimulation of B cell genesis by in vivo treatment with anti-c-kit antibody.
    Rico-Vargas SA; Weiskopf B; Nishikawa S; Osmond DG
    J Immunol; 1994 Mar; 152(6):2845-52. PubMed ID: 7511630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergy of IL-1 and stem cell factor in radioprotection of mice is associated with IL-1 up-regulation of mRNA and protein expression for c-kit on bone marrow cells.
    Neta R; Oppenheim JJ; Wang JM; Snapper CM; Moorman MA; Dubois CM
    J Immunol; 1994 Aug; 153(4):1536-43. PubMed ID: 7519205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tyrosine-containing activation motif-dependent phagocytosis in mast cells.
    Daëron M; Malbec O; Bonnerot C; Latour S; Segal DM; Fridman WH
    J Immunol; 1994 Jan; 152(2):783-92. PubMed ID: 8283051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stem cell factor augments Fc epsilon RI-mediated TNF-alpha production and stimulates MAP kinases via a different pathway in MC/9 mast cells.
    Ishizuka T; Kawasome H; Terada N; Takeda K; Gerwins P; Keller GM; Johnson GL; Gelfand EW
    J Immunol; 1998 Oct; 161(7):3624-30. PubMed ID: 9759885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intrinsic human glomerular mesangial cells can express receptors for IgG complexes (hFc gamma RIII-A) and the associated Fc epsilon RI gamma-chain.
    Radeke HH; Gessner JE; Uciechowski P; Mägert HJ; Schmidt RE; Resch K
    J Immunol; 1994 Aug; 153(3):1281-92. PubMed ID: 8027555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of stem cell factor on the growth and radiation survival of tumor cells.
    Shui C; Khan WB; Leigh BR; Turner AM; Wilder RB; Knox SJ
    Cancer Res; 1995 Aug; 55(15):3431-7. PubMed ID: 7542170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early expression of high-affinity receptor for immunoglobulin E (Fc epsilon RI) during differentiation of mouse mast cells and human basophils.
    Thompson HL; Metcalfe DD; Kinet JP
    J Clin Invest; 1990 Apr; 85(4):1227-33. PubMed ID: 2138633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential responsiveness of purified mouse c-kit+ mast cells and their progenitors to IL-3 and stem cell factor.
    Lantz CS; Huff TF
    J Immunol; 1995 Oct; 155(8):4024-9. PubMed ID: 7561112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of integrin expression during mast cell differentiation.
    Ducharme LA; Weis JH
    Eur J Immunol; 1992 Oct; 22(10):2603-7. PubMed ID: 1382993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor necrosis factor-alpha inhibits stem cell factor-induced proliferation of human bone marrow progenitor cells in vitro. Role of p55 and p75 tumor necrosis factor receptors.
    Rusten LS; Smeland EB; Jacobsen FW; Lien E; Lesslauer W; Loetscher H; Dubois CM; Jacobsen SE
    J Clin Invest; 1994 Jul; 94(1):165-72. PubMed ID: 7518828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fc gamma R-mediated endocytosis and expression of cell surface Fc gamma RIIb1 and Fc gamma RIIb2 by mouse bone marrow culture-derived progenitor mast cells.
    Lobell RB; Austen KF; Katz HR
    J Immunol; 1994 Jan; 152(2):811-8. PubMed ID: 8283054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of interleukin-3 with or without the c-kit ligand, stem cell factor, on the survival and cytoplasmic granule formation of mouse basophils and mast cells in vitro.
    Dvorak AM; Seder RA; Paul WE; Morgan ES; Galli SJ
    Am J Pathol; 1994 Jan; 144(1):160-70. PubMed ID: 7507298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Steel factor supports the cycling of isolated human CD34+ cells in the absence of other growth factors.
    Gore SD; Amin S; Weng LJ; Civin CI
    Exp Hematol; 1995 May; 23(5):413-21. PubMed ID: 7536683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of c-kit by mesenteric lymph node cells from Nippostrongylus brasiliensis-infected mice and by mast cell colonies developing from these cells in response to 3T3 fibroblast-conditioned medium.
    Leftwich JA; Westin EH; Huff TF
    J Immunol; 1992 May; 148(9):2894-8. PubMed ID: 1374104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetics of the appearance of Fc epsilon RI-bearing cells in interleukin-3-dependent mouse bone marrow cultures: correlation with histamine content and mast cell maturation.
    Rottem M; Barbieri S; Kinet JP; Metcalfe DD
    Blood; 1992 Feb; 79(4):972-80. PubMed ID: 1531309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro effect of stem cell factor on colony growth from acquired severe aplastic anemia.
    Bacigalupo A; Piaggio G; Podestá M; Raffo MR; Tedone E; Sogno G; Benvenuto F; Figari O; Grassia L; Bagnara GP
    Stem Cells; 1993 Jul; 11 Suppl 2():175-9. PubMed ID: 7691324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymphotactin gene expression in mast cells following Fc(epsilon) receptor I aggregation: modulation by TGF-beta, IL-4, dexamethasone, and cyclosporin A.
    Rumsaeng V; Vliagoftis H; Oh CK; Metcalfe DD
    J Immunol; 1997 Feb; 158(3):1353-60. PubMed ID: 9013979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chimeric Fc receptors identify immunoglobulin-binding regions in human Fc gamma RII and Fc epsilon RI.
    Hulett MD; McKenzie IF; Hogarth PM
    Eur J Immunol; 1993 Mar; 23(3):640-5. PubMed ID: 8449212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absence of immature mast cells in the skin of Ws/Ws rats with a small deletion at tyrosine kinase domain of the c-kit gene.
    Onoue H; Maeyama K; Nomura S; Kasugai T; Tei H; Kim HM; Watanabe T; Kitamura Y
    Am J Pathol; 1993 Apr; 142(4):1001-7. PubMed ID: 7682755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The c-kit proto-oncogene receptor is expressed on a subset of human CD3-CD4-CD8- (triple-negative) thymocytes.
    deCastro CM; Denning SM; Langdon S; Vandenbark GR; Kurtzberg J; Scearce R; Haynes BF; Kaufman RE
    Exp Hematol; 1994 Sep; 22(10):1025-33. PubMed ID: 7522182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.